These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25955836)

  • 1. Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.
    Auld AF; Alfredo C; Macassa E; Jobarteh K; Shiraishi RW; Rivadeneira ED; Houston J; Spira TJ; Ellerbrock TV; Vaz P
    Pediatr Infect Dis J; 2015 Aug; 34(8):e191-9. PubMed ID: 25955836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland.
    Auld AF; Nuwagaba-Biribonwoha H; Azih C; Kamiru H; Baughman AL; Agolory S; Abrams E; Ellerbrock TV; Okello V; Bicego G; Ehrenkranz P
    Pediatr Infect Dis J; 2016 Aug; 35(8):886-93. PubMed ID: 26849157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Ekra KA; Shiraishi RW; Tuho MZ; Kouakou JS; Mohamed F; Ettiègne-Traoré V; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    PLoS One; 2014; 9(5):e98183. PubMed ID: 24866468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services.
    Auld AF; Kamiru H; Azih C; Baughman AL; Nuwagaba-Biribonwoha H; Ehrenkranz P; Agolory S; Sahabo R; Ellerbrock TV; Okello V; Bicego G
    J Acquir Immune Defic Syndr; 2015 May; 69(1):e1-12. PubMed ID: 25942465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.
    Auld AF; Mbofana F; Shiraishi RW; Sanchez M; Alfredo C; Nelson LJ; Ellerbrock T
    PLoS One; 2011 Apr; 6(4):e18453. PubMed ID: 21483703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.
    Blevins M; José E; Bilhete FR; Vaz LM; Shepherd BE; Audet CM; Vermund SH; Moon TD
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):198-207. PubMed ID: 25381732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes Among Children Enrolled in HIV Care in Mozambique 2009-2013.
    Teasdale CA; Yang J; Thome B; Yersin I; Sebastian T; Brusamento S; Lahuerta M; Jobarteh KM; Abrams EJ
    Pediatr Infect Dis J; 2016 Oct; 35(10):1117-25. PubMed ID: 27622685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community ART Support Groups in Mozambique: The Potential of Patients as Partners in Care.
    Jobarteh K; Shiraishi RW; Malimane I; Samo Gudo P; Decroo T; Auld AF; Macome V; Couto A
    PLoS One; 2016; 11(12):e0166444. PubMed ID: 27907084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Decade of Antiretroviral Therapy Scale-up in Mozambique: Evaluation of Outcome Trends and New Models of Service Delivery Among More Than 300,000 Patients Enrolled During 2004-2013.
    Auld AF; Shiraishi RW; Couto A; Mbofana F; Colborn K; Alfredo C; Ellerbrock TV; Xavier C; Jobarteh K
    J Acquir Immune Defic Syndr; 2016 Oct; 73(2):e11-22. PubMed ID: 27454248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.
    Ardura-Garcia C; Feldacker C; Tweya H; Chaweza T; Kalulu M; Phiri S; Wang D; Weigel R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):e160-7. PubMed ID: 26218409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.
    Marazzi MC; De Luca S; Palombi L; Scarcella P; Ciccacci F; Ceffa S; Nielsen-Saines K; De Luca A; Mancinelli S; Gennaro E; Zimba I; Liotta G; Buonomo E
    Pediatr Infect Dis J; 2014 Mar; 33(3):295-300. PubMed ID: 23799517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
    BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand.
    Teeraananchai S; Kerr SJ; Puthanakit T; Bunupuradah T; Ruxrungtham K; Chaivooth S; Law MG; Chokephaibulkit K
    J Pediatr; 2017 Sep; 188():210-216.e1. PubMed ID: 28606372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of a pediatric HIV treatment program in Maputo, Mozambique: a cohort study.
    Walter J; Molfino L; Moreno V; Edwards CG; Chissano M; Prieto A; Bocharnikova T; Antierens A; Lujan J
    Glob Health Action; 2015; 8():26652. PubMed ID: 26287397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.